[{"AccountsPayableCurrent_0_Q2_USD":7437000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":15000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1377000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":73006000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-14883000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-7169000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-1320000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2173000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-9000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":3000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10876000.0,"OtherAssetsNoncurrent_0_Q2_USD":965000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12830000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10031000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3888000.0,"OperatingLeaseLiability_0_Q2_USD":13919000.0,"OperatingIncomeLoss_2_Q2_USD":-65720000.0,"OperatingIncomeLoss_1_Q2_USD":-31501000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"NetIncomeLoss_2_Q2_USD":-80652000.0,"NetIncomeLoss_1_Q2_USD":-38688000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-50194000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-21395000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-25000.0,"LiabilitiesCurrent_0_Q2_USD":108086000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4327000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":0.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":52988000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":72484000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":46197656.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":46153613.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":91000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":998000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":-13000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":90930.0,"StockholdersEquity_0_Q2_USD":-39614000.0,"ShortTermInvestments_0_Q2_USD":108331000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":17.33,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":37.65,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.3,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":26.46,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8720650.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":18969000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":605896.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":382930.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":26.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":6625447.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":18131000.0,"ShareBasedCompensation_2_Q2_USD":16745000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":67140000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":34542000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":50155000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":27185000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1159753000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":35858000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17967000.0,"RepaymentsOfDebt_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":52715000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":355528000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46153613.0,"Liabilities_0_Q2_USD":395142000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":24244000.0,"CommonStockSharesIssued_0_Q2_shares":46994403.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-71614000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":188287000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":79956000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":79956000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":727000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":108331000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":108392000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":61000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":46994403.0,"AssetsFairValueDisclosure_0_Q2_USD":188287000.0,"Assets_0_Q2_USD":355528000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9509572.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":9509572.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":16745000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7996000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8363000.0,"AdjustmentForAmortization_2_Q2_USD":14948000.0,"AdditionalPaidInCapital_0_Q2_USD":1120153000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-61000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":19769000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2498000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":96761000.0,"AccountsReceivableNetCurrent_0_Q2_USD":59151000.0,"AssetsCurrent_0_Q2_USD":289018000.0,"CommonStockValue_0_Q2_USD":47000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-38685000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-80661000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3840000.0,"InventoryNet_0_Q2_USD":30704000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2620000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2532000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3173000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":1970000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":3129000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":4082000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":49000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":18000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-80603000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-38670000.0,"EquitySecuritiesFvNiRealizedGainLoss_2_Q2_USD":-1000000.0,"EquitySecuritiesFvNi_0_Q2_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":11848000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.84,"EarningsPerShareDiluted_2_Q2_USD":-1.75,"EarningsPerShareBasic_2_Q2_USD":-1.75,"EarningsPerShareBasic_1_Q2_USD":-0.84,"Depreciation_2_Q2_USD":3161000.0,"DebtInstrumentConvertibleThresholdTradingDays_2_Q2_D":20.0,"DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_2_Q2_D":30.0,"CostsAndExpenses_2_Q2_USD":115875000.0,"CostsAndExpenses_1_Q2_USD":58686000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":12877000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":6177000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":222023000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":52829000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":73724000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":108331000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46197656.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]